A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.
Phase of Trial: Phase II
Latest Information Update: 11 Jan 2019
At a glance
- Drugs Enzalutamide (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms EXCALIBUR
- 21 Apr 2017 Status changed from active, no longer recruiting to recruiting.
- 07 Apr 2017 New trial record